Strategic staffing

The benefits of strategic staffing solutions

You can rely on R&D Partners to recruit uniquely talented professionals to meet your strategic life science staffing needs. Whether your staffing needs involve a clinical trial or a critical research & development project we will partner with you to assess the specific needs of your team and then pair those needs with experienced industry professionals. As a niche life science provider, we take pride in assessing your staffing needs to determine how our team can provide you with the most qualified resources to meet your project timelines and objectives.

Strategic resource management is critical to the success for any pharmaceutical, medical device or diagnostic company, partner with us in the following areas:

Scientific

Clinical research

Engineering

Our process

Strategic staffing starts with an experienced life science recruitment team, we begin with a detailed assessment of your current project needs and determine the unique skills and experience that is required. We then identify appropriate candidates utilizing our extensive database, market knowledge and our vast network of life science professionals. Once identified, candidates complete a screening process which includes thorough interviews, evaluation and reference checks. 

As a niche life science provider, we take pride in providing accurate and pertinent information on each candidate that is presented to assist you with your selection.

Partner with our strategic staffing team

Latest news

Insights for job seekers and employers alike.

The Impact of AI on Life Sciences
The arrival of artificial intelligence (AI) in the life sciences field has driven the industry ... READ MORE
BMS’s Breyanzi is the first CAR-T Cell Therapy approved for two types of leukemia
Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel) has made history as the first CAR-T therapy approved ... READ MORE
AstraZeneca Expands Rare Disease Portfolio with $1.05 Billion Amolyt Acquisition
AstraZeneca's acquisition of Amolyt Pharma for $1.05 billion is a big step toward growing its ... READ MORE